Literature DB >> 25272264

Expenditures on the treatment of osteoporosis in the elderly in Brazil (2008 - 2010): analysis of associated factors.

Luci Fabiane Scheffer Moraes1, Everton Nunes da Silva2, Diego Augusto Santos Silva3, Ana Patrícia de Paula1.   

Abstract

OBJECTIVE: To analyze the expenditure of the Ministry of Health with osteoporosis treatment in the Brazilian Public Health System (SUS) in 2008-2010 triennium and estimate the influence of demographic, regional and disease related variables on average expenditure per procedures performed.
METHODS: A cross-sectional, descriptive and analytical study based on secondary data from DATASUS related to procedures for the elderly with a diagnosis of osteoporosis and related fractures. For the statistical analysis and multivariate model, Stata 11.0 was used.
RESULTS: According to the findings, 3,252,756 procedures related to the osteoporosis treatment among the elderly were carried out in Brazil during the 2008 - 2010 period, totalizing R$ 288,986,335.15. The age group that most had procedures was 60 - 69 years (46.3%); the population of 80 years or older showed the highest spending per procedure, around R$ 106 million in three years. The women were majority in terms of quantity (95.6%) and expense (76%) of procedures. The average cost per procedure showed a large gap between men and women, nearly 7 times (R$ 480.14 versus R$ 70.85, respectively). The ambulatory care procedures predominated in quantity (96.4%) and the hospital procedures predominated in resources (70.4%). It was found that there is no single standard for groups of procedures when these are analyzed separately.
CONCLUSION: A disaggregated analysis of expenditure by procedures groups extracted from the SUS Management System of the Table of Procedures, Medicines, Orthotics, Prosthetics and Special Materials allowed a detailed overview of federal spending on the osteoporosis treatment in the elderly from Brazil.

Entities:  

Mesh:

Year:  2014        PMID: 25272264     DOI: 10.1590/1809-4503201400030012

Source DB:  PubMed          Journal:  Rev Bras Epidemiol        ISSN: 1415-790X


  5 in total

1.  A single whole body vibration session influences quadriceps muscle strength, functional mobility and balance of elderly with osteopenia and/or osteoporosis? Pragmatic clinical trial.

Authors:  Luanda Alves Xavier Ramos; François Talles Medeiros Rodrigues; Lívia Shirahige; Maria de Fátima Alcântara Barros; Antônio Geraldo Cidrão de Carvalho; Marcelo Renato Guerino; Ana Paula de Lima Ferreira; Ricardo Oliveira Guerra; Maria das Graças Rodrigues de Araújo
Journal:  J Diabetes Metab Disord       Date:  2019-02-27

Review 2.  The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil.

Authors:  Luiz Francisco Baccaro; Délio Marques Conde; Lúcia Costa-Paiva; Aarão Mendes Pinto-Neto
Journal:  Clin Interv Aging       Date:  2015-03-20       Impact factor: 4.458

3.  Track and Field Practice and Bone Outcomes among Adolescents: A Pilot Study (ABCD-Growth Study).

Authors:  Yuri da Silva Ventura Faustino-da-Silva; Ricardo Ribeiro Agostinete; André Oliveira Werneck; Santiago Maillane-Vanegas; Kyle Robinson Lynch; Isabella Neto Exupério; Igor Hideki Ito; Romulo Araújo Fernandes
Journal:  J Bone Metab       Date:  2018-02-28

4.  Monitoring bone changes due to calcium, magnesium, and phosphorus loss in rat femurs using Quantitative Ultrasound.

Authors:  Aldo Fontes-Pereira; Paulo Rosa; Thiago Barboza; Daniel Matusin; Aline Soares Freire; Bernardo Ferreira Braz; Christiano Bittencourt Machado; Marco Antônio von Krüger; Sergio Augusto Lopes de Souza; Ricardo Erthal Santelli; Wagner Coelho de Albuquerque Pereira
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379

5.  PROFILE OF PATIENTS WITH OSTEOPOROTIC FRACTURES AND FACTORS THAT DECREASE PREVENTION.

Authors:  Renato Martins Xavier; Ivan Carvalho Giarola; Guilherme Pereira Ocampos; Pérola Grinberg Plapler; Olavo Pires de Camargo; Márcia Uchôa de Rezende
Journal:  Acta Ortop Bras       Date:  2019 Mar-Apr       Impact factor: 0.513

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.